| 引用本文:刘子豪，刘红旭，尚菊菊，邢文龙，来晓磊，周琦.中成药治疗原发性高血压随机对照临床试验综述[J].世界中医药,2020,(22):. |
|
| 中成药治疗原发性高血压随机对照临床试验综述 |
| A Summary of Randomized Controlled Clinical Trials of Chinese Patent Medicine in the Treatment of Essential Hypertension |
| 投稿时间：2019-08-27 |
| DOI：10.3969/j.issn.1673-7202.2020.22.031 |
| 中文关键词: 中成药 原发性高血压 随机对照临床试验 |
| English Keywords:Chinese patent medicine Essential hypertension Randomized controlled clinical trial |
| 基金项目:北京市医管局扬帆计划重点医学专业（中医心血管病）项目（ZYLX201817）；国家中医药管理局国家中医临床研究基地业务建设科研专项课题（JDZX2015151）——基于大数据分析的高血压患者症候表型特征与代谢组学点研究 |
|
| 摘要点击次数: 346 |
| 全文下载次数: 0 |
| 中文摘要: |
| 高血压是临床常见疾病，中成药治疗原发性高血压有效，并具有改善症状明显、个体化强等优势，笔者对近年来中成药治疗原发性高血压的随机对照临床试验归纳整理，进行综述如下。 |
| English Summary: |
| Hypertension is a common clinical disease.Chinese patent medicine is effective in the treatment of essential hypertension，and has the advantages of obvious improvement of symptoms and strong individualization.This paper summarizes the randomized controlled clinical trials of Chinese patent medicine in the treatment of primary hypertension in recent years，which are as follows. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
